Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 05 Jan 2024

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions

in Hematologic Malignancies

Rubí Romo-Rodríguez
Gabriela Zamora-Herrera
Jebea A. López-Blanco
Lucero López-García
Arely Rosas-Cruz
Laura Alfaro-Hernández
César Omar Trejo-Pichardo
Dulce Rosario Alberto-Aguilar
Diana Casique-Aguirre
Armando Vilchis-Ordoñez

Frontiers in Oncology

doi 10.3389/fonc.2023.1304662

7,160 views
1 citation

Brief Research Report

Published on 04 Jan 2024

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

in Hematologic Malignancies

Zhuanghui Hao
Juan Li
Feng Gao
Weixiao Ren
Xiaomei Lu
Jinyi Feng
Chen Zhang
Sicheng Bian
Juan Xie
Ming Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1265022

2,468 views

Original Research

Published on 04 Jan 2024

Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia

in Hematologic Malignancies

Ziping Li
Zhi Guo
Haitao Xiao
Xuexing Chen
Wei Liu
Hao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1331802

2,025 views
1 citation

Case Report

Published on 03 Jan 2024

Case report: EBV-positive epithelioid follicular dendritic cell sarcoma with CD30 expression: a highly challenging diagnosis

in Hematologic Malignancies

Ying Chen
Xin He
Xingyan Zhu
Yujuan Xu
Deyu Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1321565

1,662 views
1 citation

Review

Published on 20 Dec 2023

Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

in Hematologic Malignancies

Fateen Ata
Maria Benkhadra
Rola Ghasoub
Liam J. Fernyhough
Nabil E. Omar
Abdulqadir J. Nashwan
Mahmood B. Aldapt
Kamran Mushtaq
Nancy A. Kassem
Mohamed A. Yassin

Frontiers in Oncology

doi 10.3389/fonc.2023.1285346

3,287 views
2 citations

Editorial

Published on 19 Dec 2023

Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation

in Hematologic Malignancies

Nelson Hamerschlak
David Gómez-Almaguer
Donal P. McLornan

Frontiers in Oncology

doi 10.3389/fonc.2023.1321334

1,355 views
1 citation

Review

Published on 15 Dec 2023

Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential

in Hematologic Malignancies

Anna Maria Cacic
Felicitas Isabel Schulz
Ulrich Germing
Sascha Dietrich
Norbert Gattermann

Frontiers in Oncology

doi 10.3389/fonc.2023.1303785

6,554 views
5 citations

Systematic Review

Published on 14 Dec 2023

Prevalence and prognostic value of baseline sarcopenia in hematologic malignancies: a systematic review

in Hematologic Malignancies

Xiaofeng Zeng
Liying Zhang
Yu Zhang
Shuli Jia
Taiping Lin
Xuman Zhao
Xiaoli Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1308544

2,250 views
2 citations

Editorial

Published on 13 Dec 2023

Editorial: Challenges in peripheral T-cell lymphomas: from biological advances to clinical applicability

in Hematologic Malignancies

Luís Alberto de Pádua Covas Lage
Juliana Pereira
Ryan A. Wilcox

Frontiers in Oncology

doi 10.3389/fonc.2023.1325170

844 views
1 citation

Case Report

Published on 13 Dec 2023

Co-existence of KMT2A::SEPTIN6 fusion and DIS3 variant in a pediatric case with acute myeloid leukemia: a case report and literature review

in Hematologic Malignancies

Liang Wang
Fangzhou Qiu
Yongming Shen
Sen Chen
Ping Si

Frontiers in Oncology

doi 10.3389/fonc.2023.1308786

1,809 views
1 citation

Mini Review

Published on 11 Dec 2023

The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma

in Hematologic Malignancies

Patrick Nylund
Berta Garrido-Zabala
Antonia Kalushkova
Helena Jernberg Wiklund

Frontiers in Oncology

doi 10.3389/fonc.2023.1303677

2,322 views
2 citations

Original Research

Published on 07 Dec 2023

Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study

in Hematologic Malignancies

Anna Cardellino
Julia R. Correll
Mona Martin
Boris Gorsh
Sandhya Sapra
Rakesh Popat

Frontiers in Oncology

doi 10.3389/fonc.2023.1274659

2,435 views
1 citation

Review

Published on 06 Dec 2023

Deep learning enhances acute lymphoblastic leukemia diagnosis and classification using bone marrow images

in Hematologic Malignancies

Basel Elsayed
Mohamed Elhadary
Raghad Mohamed Elshoeibi
Amgad Mohamed Elshoeibi
Ahmed Badr
Omar Metwally
Raghad Alaa ElSherif
Mohamed Elsayed Salem
Fatima Khadadah
Awni Alshurafa

Frontiers in Oncology

doi 10.3389/fonc.2023.1330977

5,628 views
14 citations

Brief Research Report

Published on 06 Dec 2023

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma

in Hematologic Malignancies

Angélique Bruyer
Laure Dutrieux
Hugues de Boussac
Thibaut Martin
Djamila Chemlal
Nicolas Robert
Guilhem Requirand
Guillaume Cartron
Laure Vincent
Charles Herbaux

Frontiers in Oncology

doi 10.3389/fonc.2023.1271847

2,727 views
5 citations

Review

Published on 06 Dec 2023

Molecular mechanisms of ferroptosis and its roles in leukemia

in Hematologic Malignancies

Zhe Chen
Suying Zheng
Jiongping Han
Leihua Fu
Jiaping Fu
Zhijian Zhang
Pan Hong
Weiying Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1308869

3,481 views
3 citations

Original Research

Published on 04 Dec 2023

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib

in Hematologic Malignancies

Baustin M. Welch
Bryce A. Manso
Kimberly A. Gwin
Petra K. Lothert
Sameer A. Parikh
Neil E. Kay
Kay L. Medina

Frontiers in Oncology

doi 10.3389/fonc.2023.1302038

2,158 views